Group One Trading’s 10x Genomics TXG Stock Holding History

Group One Trading’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$81.6K	Buy	+3,843	New	+$76.8K	﹤0.01%	4907
2025 Q3	–	Sell	-2,651	Closed	-$34.6K	–	9188
2025 Q2	$30.7K	Buy	+2,651	New	+$24.2K	﹤0.01%	5964
2025 Q1	–	Sell	-3,426	Closed	-$43.2K	–	8395
2024 Q4	$49.2K	Sell	3,426 -3,846	-53%	-$60.7K	﹤0.01%	5069
2024 Q3	$164K	Sell	7,272 -6,601	-48%	-$136K	﹤0.01%	3798
2024 Q2	$270K	Sell	13,873 -20,962	-60%	-$549K	﹤0.01%	3139
2024 Q1	$1.31M	Buy	+34,835	New	+$1.53M	0.01%	1851
2023 Q4	–	Sell	-3,754	Closed	-$163K	–	8220
2023 Q3	$155K	Buy	+3,754	New	+$195K	﹤0.01%	4039
2022 Q4	–	Sell	-2,203	Closed	-$72K	–	8116
2022 Q3	$63K	Buy	+2,203	New	+$83.9K	﹤0.01%	5213
2021 Q2	–	Sell	-76	Closed	-$13.8K	–	8590
2021 Q1	$14K	Buy	+76	New	+$13.1K	﹤0.01%	6917
2020 Q2	–	Sell	-8,409	Closed	-$655K	–	6191
2020 Q1	$524K	Buy	8,409 +859	+11%	+$67K	﹤0.01%	2019
2019 Q4	$576K	Buy	+7,550	New	+$454K	﹤0.01%	2322

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's TXG Position: Q1 2026 in Review

Group One Trading opened a new position in 10x Genomics (TXG) in Q1 2026: 3,843 shares worth $81.6K. The stake represents ﹤0.01% of the portfolio and ranks #4907 among its holdings. This is a return to the name: Group One Trading previously reported a position in TXG as recently as Q2 2025.

Group One Trading first reported a position in TXG in Q4 2019 and has held it in 11 quarters since. The position peaked at $1.31M in Q1 2024. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Group One Trading held 3,843 shares of 10x Genomics worth $81.6K as of Q1 2026.
10x Genomics was a new Group One Trading position in Q1 2026.
10x Genomics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4907 holding.
Group One Trading first reported a position in 10x Genomics in Q4 2019 and has held it in 11 quarters since.
Group One Trading's 10x Genomics position peaked at $1.31M in Q1 2024.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.